RxDoctor Payments Data

Zachary Smith, PA

Physician Assistant · Westminster, MDNPI 1760585723

Payments from drug & device makers

$274in general payments, 2019–2025

Across 10 payments — averaging $27.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$96
  • Exact Sciences$54
  • Lilly USA, LLC$41
  • Novo Nordisk$36
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$19
  • AbbVie$17
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$274100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$274 in reported general payments places this provider in the 60th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$162,468
Medicare patients
516
Services billed
2,583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin34$50,462
OzempicSemaglutide47$44,381
JanuviaSitagliptin Phosphate16$24,849
EliquisApixaban14$20,536
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog27$12,678
Synjardy XrEmpagliflozin/Metformin Hcl13$7,629
Lagevrio (Eua)Molnupiravir15$5,388
Atorvastatin Calcium224$3,125
PaxlovidNirmatrelvir/Ritonavir24$2,859
Levothyroxine Sodium90$2,493
Rosuvastatin Calcium94$1,909
Pantoprazole Sodium94$1,907
Metoprolol Succinate99$1,904
Losartan Potassium127$1,824
Esomeprazole Magnesium15$1,501

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$36$44,38147 claims
AbbVieSynthroid$17$1,41322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Westminster

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →